4qpf: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
Description: New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption | Description: New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption | ||
[[Category: Unreleased Structures]] | |||
[[Category: Jeans, G]] | |||
[[Category: Barnett, B.L]] | |||
[[Category: Duan, Z]] | |||
[[Category: Russell, R.G.G]] | |||
[[Category: Dunford, J.E]] | |||
[[Category: Lundy, M]] | |||
[[Category: Mazur, A]] | |||
[[Category: Triffitt, J]] | |||
[[Category: Kwaasi, A.A]] | |||
[[Category: Ebetino, F.H]] | |||
Revision as of 16:00, 24 December 2014
Unreleased structure
The entry 4qpf is ON HOLD until Paper Publication
Authors: Ebetino, F.H., Lundy, M., Kwaasi, A.A., Dunford, J.E., Duan, Z., Triffitt, J., Mazur, A., Jeans, G., Barnett, B.L., Russell, R.G.G.
Description: New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption
